Dbv Technologies S.a. - Spons-adr  logo

Dbv Technologies S.a. - Spons-adr Share Price (NASDAQ: DBVT)

$9.5

-0.29

(-2.96%)

Last updated on

Check the interactive Dbv Technologies S.a. - Spons-adr Stock chart to analyse performance

Dbv Technologies S.a. - Spons-adr stock performance

as on August 27, 2025 at 1:27 AM IST

  • Today's Low:$9.50
    Today's High:$9.61

    Day's Volatility :1.14%

  • 52 Weeks Low:$2.20
    52 Weeks High:$12.78

    52 Weeks Volatility :82.75%

Dbv Technologies S.a. - Spons-adr Stock Returns

PeriodDbv Technologies S.a. - Spons-adr Sector (Health Care)Index (Russel 2000)
3 Months
1.6%
3.1%
0.0%
6 Months
128.09%
-7.5%
0.0%
1 Year
115.91%
-12.5%
0.0%
3 Years
-53.88%
7.0%
-6.9%

Dbv Technologies S.a. - Spons-adr Key Stats

Check Dbv Technologies S.a. - Spons-adr key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$9.79
Open
$9.59
Today's High
$9.61
Today's Low
$9.5
Market Capitalization
$271.8M
Today's Volume
$8.0K
52 Week High
$12.78
52 Week Low
$2.2045
Revenue TTM
$3.8M
EBITDA
$-79.7M
Earnings Per Share (EPS)
$-5.6
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-148.09%

Stock Returns calculator for Dbv Technologies S.a. - Spons-adr Stock including INR - Dollar returns

The Dbv Technologies S.a. - Spons-adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Dbv Technologies S.a. - Spons-adr investment value today

Current value as on today

₹2,20,335

Returns

₹1,20,335

(+120.34%)

Returns from Dbv Technologies S.a. - Spons-adr Stock

₹1,15,909 (+115.91%)

Dollar Returns*

₹4,426 (+4.43%)

Indian investors sentiment towards Dbv Technologies S.a. - Spons-adr Stock

-55%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Search interest for Dbv Technologies S.a. - Spons-adr Stock from India on INDmoney has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Dbv Technologies S.a. - Spons-adr

  • Name

    Holdings %

  • Baker Bros Advisors LP

    5.34%

  • MPM Oncology Impact Management LP

    3.85%

  • Octagon Capital Advisors LP

    3.72%

  • Yiheng Capital LLC

    2.40%

  • Great Point Partners LLC

    1.37%

  • UBS Group AG

    0.60%

Analyst Recommendation on Dbv Technologies S.a. - Spons-adr Stock

Rating
Trend

Buy

    75%Buy

    12%Hold

    12%Sell

Based on 8 Wall street analysts offering stock ratings for Dbv Technologies S.a. - Spons-adr (by analysts ranked 0 to 5 stars)

Dbv Technologies S.a. - Spons-adr Share Price Target

What analysts predicted

Upside of 68.78%

Target:

$16.03

Current:

$9.50

Dbv Technologies S.a. - Spons-adr share price target is $16.03, a slight Upside of 68.78% compared to current price of $9.50 as per analysts' prediction.

Dbv Technologies S.a. - Spons-adr Stock Insights

  • Price Movement

    In the last 6 months, DBVT stock has moved up by 138.6%
  • Decreasing Revenue

    Revenue is down for the last 5 quarters, 8.87M → 511.0K (in $), with an average decrease of 40.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -23.01M → -33.11M (in $), with an average decrease of 20.0% per quarter
  • DBVT vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 110.3% return, outperforming this stock by 162.6%

Dbv Technologies S.a. - Spons-adr Technicals Summary

Sell

Neutral

Buy

Dbv Technologies S.a. - Spons-adr is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Dbv Technologies S.a. - Spons-adr Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Dbv Technologies S.a. - Spons-adr  logo
2.98%
128.09%
115.91%
-53.88%
-54.11%
Regeneron Pharmaceuticals, Inc. logo
2.56%
-16.9%
-51.12%
-0.89%
-2.51%
Beone Medicines Ltd logo
5.47%
18.87%
52.28%
84.02%
26.72%
Vertex Pharmaceuticals Incorporated logo
-15.59%
-19.22%
-19.42%
37.43%
43.36%
Alnylam Pharmaceuticals, Inc. logo
36.58%
84.99%
60.96%
115.82%
243.29%

About Dbv Technologies S.a. - Spons-adr

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. The company's product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. Its earlier stage research programs include vaccine for the respiratory syncytial virus, potential treatments for inflammatory bowel disease, celiac disease, and type I diabetes. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.
Organization
Dbv Technologies S.a. - Spons-adr
Employees
109
CEO
Mr. Daniel Tassé
Industry
Health Technology

Key Management of Dbv Technologies S.a. - Spons-adr

NameTitle
Mr. Daniel Tassé
CEO & Director
Ms. Virginie Simone Jeanine Verrechia Boucinha M.B.A.
Chief Financial Officer
Dr. Pharis Mohideen M.D.
Chief Medical Officer
Dr. Kevin P. Malobisky M.S., Ph.D., R.A.C.
Chief Operations Officer
Ms. Michele F. Robertson
Chief Legal Officer
Mr. James Briggs
Chief Human Resources Officer
Ms. Caroline Daniere
Chief of Staff
Alan Kerr
Senior VP & Head of Global Regulatory Affairs
Mr. Pascal Wotling
Chief External Manufacturing & Supply Chain Officer
Dr. Robert G. Pietrusko Pharm. D., Pharm.D.
Chief Regulatory Officer

Important FAQs about investing in DBVT Stock from India :

What is Dbv Technologies S.a. - Spons-adr share price today?

Dbv Technologies S.a. - Spons-adr share price today is $9.50 as on at the close of the market. Dbv Technologies S.a. - Spons-adr share today touched a day high of $9.61 and a low of $9.50.

What is the 52 week high and 52 week low for Dbv Technologies S.a. - Spons-adr share?

Dbv Technologies S.a. - Spons-adr share touched a 52 week high of $12.78 and a 52 week low of $2.20. Dbv Technologies S.a. - Spons-adr stock price today i.e. is closed at $9.50, lower by 25.67% versus the 52 week high.

How to invest in Dbv Technologies S.a. - Spons-adr Stock (DBVT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Dbv Technologies S.a. - Spons-adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dbv Technologies S.a. - Spons-adr Shares that will get you 0.1579 shares as per Dbv Technologies S.a. - Spons-adr share price of $9.50 per share as on August 27, 2025 at 1:27 AM IST.

What is the minimum amount required to buy Dbv Technologies S.a. - Spons-adr Stock (DBVT) from India?

Indian investors can start investing in Dbv Technologies S.a. - Spons-adr (DBVT) shares with as little as ₹87.6525 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.53 in Dbv Technologies S.a. - Spons-adr stock (as per the Rupee-Dollar exchange rate as on August 27, 2025). Based on Dbv Technologies S.a. - Spons-adr share’s latest price of $9.50 as on August 27, 2025 at 1:27 AM IST, you will get 1.0526 shares of Dbv Technologies S.a. - Spons-adr . Learn more about fractional shares .

What are the returns that Dbv Technologies S.a. - Spons-adr has given to Indian investors in the last 5 years?

Dbv Technologies S.a. - Spons-adr stock has given -54.11% share price returns and 18.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?